TrialHuman vaccines & immunotherapeutics2020

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study.

Judith Kirstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.